Tag Page Excerpt: Novavax stock cratered today despite positive clinical trial data for its RSV F vaccine.
While the data was positive, it did little to assure investors that the vaccine would make it to phase 3 trials and beyond.
Here's what you need to know about NVAX today...
Tags:biotech stocks
To get full access to all Money Morning content, click here
About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.
Disclaimer:© 2017 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.
The post Why Is Novavax Stock Down Today? appeared first on Money Morning - We Make Investing Profitable.